Utility of HLA‐DR in screening panel for inborn errors of immunity
- 26 December 2022
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 97 (3)
Abstract
A comprehensive evaluation of immune parameters while screening for inborn errors of immunity (IEIs) provides valuable information about the underlying defect. In 2019, the ICMR‐National Institute of Immunohaematology adopted a screening panel modified from the Euroflow consortium‐recommended PIDOT tube, the difference being the addition of HLA‐DR. In the present study, we evaluate the utility of HLA‐DR in our screening panel. The HLA‐DR expression on CD3 + T, its CD4+ and CD8+ subsets, natural killer (NK) and double‐negative T cells (DNT) was compared between patients and controls. HLA‐DR expression on CD3+ T cells or its subsets was significantly elevated in SCID and Omenn's phenotype (P <.001), combined immunodeficiencies (P < .05) including DOCK8 and WAS, diseases of immune dysregulation including FHL (P < .0001) and ALPS (P < .05) and CVID with complications (P < .05). An absence of HLA‐DR marker can help in identifying cases of MHC II deficiency at the time of screening including atypical cases which present without reduction in CD4+ T cell counts and reversal of CD4+/CD8+ ratio. ROC analysis revealed a cut‐off of 14.62%, 19.11% and 1.5% for percentage HLA‐DR expression on CD3+ and CD8+ T cells and HLA‐DR on CD8/HLA‐DR on CD4, respectively, for FHL. Random forest analysis identified HLA‐DR (%) on NK cells, ratio of HLA‐DR CD8+/HLA‐DR CD4+, NK cell (%), T cell (%), HLA‐DR+ CD8(%) and CD45pos NK cell (%) as important predictors for FHL. Evaluation of HLA‐DR expression during screening can provide corroborative clues to the diagnosis of underlying IEI along with other immunological abnormalities.Keywords
Funding Information
- Indian Council of Medical Research (61/02/2012/IMM/BMS)
This publication has 14 references indexed in Scilit:
- Application of Flow Cytometry in Primary Immunodeficiencies: Experience From IndiaFrontiers in Immunology, 2019
- Multicolor Flow Cytometry for the Diagnosis of Primary Immunodeficiency DiseasesJournal of Clinical Immunology, 2017
- Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T‐cell activation, differentiation and repertoireEuropean Journal of Immunology, 2016
- Diagnostics of Primary Immunodeficiencies through Next-Generation SequencingFrontiers in Immunology, 2016
- Application of Flow Cytometry in the Evaluation of Primary ImmunodeficienciesIndian Journal of Pediatrics, 2016
- Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping ConsortiumScientific Reports, 2016
- The who's who of T‐cell differentiation: Human memory T‐cell subsetsEuropean Journal of Immunology, 2013
- Characterizing T Cells in SCID Patients Presenting with Reactive or Residual T LymphocytesJournal of Immunology Research, 2012
- Human peripheral blood B‐cell compartments: A crossroad in B‐cell trafficCytometry Part B: Clinical Cytometry, 2010
- The HLA Region and Autoimmune Disease: Associations and Mechanisms of ActionCurrent Genomics, 2007